Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.！
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Lauratinib Intermediate
Lauratinib (Pf-06463922) Is An Experimental Antineoplastic Drug Developed By Pfizer. It Is An Oral Ros-1 And Alk Small Molecule Inhibitor. Loratinib Can Cross The Blood-Brain Barrier.
No data
